Toggle navigation
Home
Search
Services
Blog
Contact
About
Therapy for Chemotherapy Alopecia with Pthrp Analogs
Holick, Michael F.
Cutanogen, Inc., Sudbury, MA, United States
Search 146 grants from Michael Holick
Search grants from Cutanogen, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Causal Analysis of Electrically Connected Neural Networks
Human Phenotyping Core
Functional Analysis of Novel GABA Receptor in Drosophila
Genetic Architecture and Evolution of Reproductive Caste Determination in Harvester Ants
An Evolving Program to Prepare Information Technologists in Southwest Ohio for the 21st Century
Recently added grants:
Development of Methods for Precise MR-guided Hyperthermia Delivery for Targeted Cancer Therapies
Mutational spectra of bulky DNA lesions
Targeting M1/M3 Muscarinic Receptors to Treat Gestational Pesticide Poisoning
DNA adductome of human bladder from the tobacco exposome
Enhanced Care Planning and Clinical-Community Linkages to Comprehensively Address the Basic Needs of Patients with Multiple Chronic Conditions
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41CA071119-01
Application #
2114842
Study Section
Special Emphasis Panel (ZRG7-SSS-Z (15))
Project Start
1996-08-01
Project End
1997-11-30
Budget Start
1996-08-01
Budget End
1997-11-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Cutanogen, Inc.
Department
Type
DUNS #
City
Sudbury
State
MA
Country
United States
Zip Code
01776
Publications
Peters, E M; Foitzik, K; Paus, R et al.
(2001)
A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.
J Invest Dermatol 117:173-8
Comments
Be the first to comment on Michael Holick's grant